Search results for " bleeding."

showing 10 items of 139 documents

Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain

2018

Aim: To analyze the clinical profile and rates of stroke, major bleeding and intracranial hemorrhage of patients with atrial fibrillation (AF) treated with rivaroxaban in clinical practice. Methods: Retrospective study of AF patients anticoagulated with rivaroxaban in a Healthcare Area of Valencia, Spain. Patients started treatment with rivaroxaban from July 2012 to December 2015. Results: A total of 230 patients (mean age 76.9 ± 9.9 years; CHA2DS2-VASc 4.3 ± 1.7; HAS-BLED 1.7 ± 0.9) were included. Rates of stroke, major bleeding and intracranial bleeding were 0.4, 1.9 and 0.5 events per 100 patient-years, respectively. Conclusion: In this cohort of AF patients anticoagulated with rivaroxa…

Malemedicine.medical_specialtyHemorrhage030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRivaroxabanRisk FactorsInternal medicineAtrial FibrillationmedicineHumansIn patient030212 general & internal medicinePractice Patterns Physicians'StrokeAgedRetrospective StudiesAged 80 and overRivaroxabanbusiness.industryRetrospective cohort studyMean ageAtrial fibrillationmedicine.diseaseStrokeSpainCohortMolecular MedicineFemaleCardiology and Cardiovascular MedicinebusinessMajor bleedingFactor Xa Inhibitorsmedicine.drugFuture Cardiology
researchProduct

Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience

2019

Abstract Background Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is one of the leading causes of death in patients with non-variceal bleeding, resulting in up to 10% mortality rate, and the patient group at high risk of rebleeding (Forrest IA, IB, and IIA) often requires additional therapy after endoscopic hemostasis. Preventive transarterial embolization (P-TAE) after endoscopic hemostasis was introduced in our institution in 2014. The aim of the study is an assessment of the intermediate results of P-TAE following primary endoscopic hemostasis in patients with serious comorbid conditions and high risk of rebleeding. Methods During the period from 2014 to 2018, a tota…

Malemedicine.medical_specialtyLeft gastric arteryTransarterial embolizationmedicine.medical_treatmentlcsh:SurgeryNon-variceal gastrointestinal bleeding030230 surgeryGastroduodenal artery03 medical and health sciences0302 clinical medicineRecurrencePreventivemedicine.arterymedicineHumansEmbolizationAgedAged 80 and overbusiness.industryMortality rateHemostasis Endoscopiclcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RD1-811lcsh:RC86-88.9Middle Agedmedicine.diseaseEmbolization TherapeuticSurgeryPeptic Ulcer HemorrhageTreatment OutcomeEmergency MedicineFemale030211 gastroenterology & hepatologySurgeryFresh frozen plasmaUpper gastrointestinal bleedingPacked red blood cellsRockall scorebusinessResearch ArticleWorld Journal of Emergency Surgery
researchProduct

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report.

2006

Bleeding prophylaxis in a child with cleft palate and factor VII deficiency: a case report. Pirrello R, Siragusa S, Giambona C, D'Arpa S, Cordova A, Moschella F. Source Dipartimento di Discipline Chirurgiche ed Oncologiche, Sezione di Chirurgia Plastica e Ricostruttiva, Università di Palermo, Palermo, Italy. Abstract The association between factor VII deficiency and cleft palate has never been described. The case of a child with cleft palate and factor VII deficiency who successfully underwent palatoplasty is described in this article. To allow surgical treatment, through maintenance of a normal prothrombin time, the patient was given 15 microg/kg of recombinant factor VIIa every 12 hours, …

Malemedicine.medical_specialtymedicine.medical_treatmentFactor VII DeficiencyPremedicationBlood Loss SurgicalFactor VIIaPostoperative HemorrhageEfficacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMedicineHumans030223 otorhinolaryngologyFactor VII deficiencyProthrombin timemedicine.diagnostic_testFactor VIIbiologybusiness.industryCoagulantsPalate030206 dentistryPerioperativePlastic Surgery ProceduresRecombinant ProteinsSurgeryCleft PalatePalatoplastyEl NiñochemistryOtorhinolaryngologyRecombinant factor VIIaAnesthesiaChild Preschoolbiology.proteinFACTOR VII DEFICIENCY CLEFT PALATE BLEEDING PROPHYLAXISProthrombin TimeOral SurgerybusinessThe Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
researchProduct

A rare complication of ERCP: Mallory-Weiss syndrome

2005

OBJECTIVE: To describe the management and outcome after endoscopic treatment of hematemesis by Mallory-Weiss Syndrome (MWS) occurred after CPRE (suspected choledocolithiasis). Background data: Although cough and retching is common during EGD or CPRE, MWS resulting from endoscopy seems to be uncommon (0.0001-0.04%) and always self-limiting. Case report: The patient was submitted to CPRE with the suspicion of choledocholithiasis. Eight hours after CPRE the patient presented with hematemesis amd hypotension. With emergency EGD, the AA identified a small bleeding mucosal tear (visible vessel with spurting) just proximal to the esophagogastric junction. The patient was safely treated with endosc…

Mallory-Weiss Syndromegastrointestinal bleedingHemorrhage
researchProduct

Gastrointestinal Bleeding In Advanced Cancer Patients

2000

Oncologymedicine.medical_specialtyGastrointestinal bleedingbusiness.industrymedicine.diseaseGastroenterologyAdvanced cancerAnesthesiology and Pain MedicineInternal medicinemedicineNeurology (clinical)Gastrointestinal cancerbusinessNursing (all)2901 Nursing (miscellaneous)General NursingJournal of Pain and Symptom Management
researchProduct

Superficial Siderosis of the Central Nervous System associated with Hemophilia A: A case report

2021

Abstract Superficial Siderosis of the Central Nervous System (SSCNS) is a condition secondary to the deposition of hemosiderin within the subpial layers of central nervous system leading to its progressive degeneration, clinically responsible for hearing impairment, cerebellar ataxia and pyramidal syndrome. Here we report the case of a 61-year-old man with medical history of congenital hemophilia A presenting with typical clinical features of SSCNS associated with extensive hypo-intensity on fast 2D gradient-echo-weighted sequences, along the spinal cord, posterior fossa's structures and cerebral cortex. Interestingly, although his disorder was revealed by a lumbar spinal stenosis, presurgi…

Pathologymedicine.medical_specialtyCentral nervous systemlcsh:SurgerySuperficial Siderosis of the Central Nervous System[INFO] Computer Science [cs]lcsh:RC346-429030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicineMedical history[INFO]Computer Science [cs]lcsh:Neurology. Diseases of the nervous systemSubclinical infectionetiological diagnosisCerebellar ataxiabusiness.industryLumbar spinal stenosislcsh:RD1-811medicine.diseaseSpinal cordSuperficial siderosis3. Good healthmedicine.anatomical_structureCongenital Hemophilia AHemosiderinchronical bleedingSurgeryNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy

2017

Factor VII deficiency is the most common among rare inherited autosomal recessive bleeding disorders, and is a chameleon disease due to the lack of a direct correlation between plasma levels of coagulation Factor VII and bleeding manifestations. Clinical phenotypes range from asymptomatic condition—even in homozygous subjects—to severe life-threatening bleedings (central nervous system, gastrointestinal bleeding). Prediction of bleeding risk is thus based on multiple parameters that challenge disease management. Spontaneous or surgical bleedings require accurate treatment schedules, and patients at high risk of severe hemorrhages may need prophylaxis from childhood onwards. The aim of the c…

Pediatricsmedicine.medical_specialtyGastrointestinal bleedingPathologyGenotypediagnosisInherited Factor VII derficiencyDiseaseReview030204 cardiovascular system & hematologyAsymptomatic03 medical and health sciences0302 clinical medicineRepalcement Therapyreplacement therapyGenotypemedicineFactor VII deficiencyClinical phenotypebusiness.industryBleedingGeneral MedicinePlasma levelsmedicine.diseasePhenotypeinherited Factor VII deficiencymedicine.symptombusiness030215 immunology
researchProduct

Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists

2012

Abstract Objectives Proton pump inhibitors (PPIs) and H2-receptor antagonists (H2RAs) present varying pharmacological efficacy in preventing stress ulcer bleeding (SUB) in intensive care units. The literature also reports disparate rates of ventilator-assisted pneumonia (VAP) as side effects of these treatments. We compared the cost-effectiveness of these two prophylactic pharmacological options. Methods We constructed a decision tree with a 60-day time horizon for patients at high risk for developing SUB, receiving either PPIs or H2RAs. For each treatment strategy, patients could be in one of three states of health: SUB, VAP, or no complication. Contemporary, clinically relevant probabilit…

Peptic Ulcermedicine.medical_specialtyMultivariate analysisDatabases FactualCost effectivenessmedicine.drug_classCost-Benefit AnalysisMEDLINEProton-pump inhibitorH2RAIntensive careInternal medicinemedicineHumanscost-effectivenessbusiness.industryHealth PolicyStress ulcerDecision TreesPublic Health Environmental and Occupational HealthProton Pump InhibitorsHealth Care CostsCost-effectiveness analysisLength of StayAnti-Ulcer Agentsmedicine.diseaseUnited StatesSurgerystress ulcer bleedingHistamine H2 AntagonistsMultivariate AnalysisGastrointestinal HemorrhagebusinessComplicationValue in Health
researchProduct

Trends in gastrointestinal bleeding in the Region of Valencia (2000-2005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid sup…

2011

Objective: To describe 2000-2005 time trends of prescription for NSAIDs, proton pump inhibitors (PPIs) and hospital admissions for gastrointestinal (GI) bleeding. Methods: Time series analysis of gastrointestinal (GI) bleeding admission and drugs’ Defined Daily Dose per 1000 people per day (DDD/1000/day) in the Region of Valencia, Spain, from January 2000 to December 2005. Results: Dispensation of NSAIDs went from 42.7 DDD/1000 people/day in 2000 to 58.3 DDD/1000 people/day in 2005. During the same period, dispensation of PPIs went from 26.3 DDD/1000 people/day to 68.5 DDD/1000 people/day (both are statistically significant). The rate of hospitalisations for gastrointestinal bleeding during…

Pharmacologymedicine.medical_specialtyGastrointestinal bleedingNonsteroidalTime FactorsGI bleedingTime trendsbusiness.industryAnti-Inflammatory Agents Non-SteroidalCommerceProton Pump Inhibitorsmedicine.diseaseSurgerychemistry.chemical_compoundDefined daily doseAcid suppressionchemistrySpainInternal medicinemedicineHumansMedical prescriptionbusinessGastrointestinal HemorrhageFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
researchProduct

Polypoid anal melanoma. A case report and review of the literature

2016

Ano-rectal melanoma is an uncommon finding in patients complaining of rectal bleeding and/or anal mass often misinterpreted as a haemorroidal pile.A 55-years-old woman, complaining of rectal bleeding, frequent anal pain and anal mass suspected for haemorroidal thrombosis was referred for evaluation and possible treatment. A brown polypoid mass arising from the anal canal/lower rectum with a maximum diameter of 6 cm was diagnosed. The hystological examination of the neoplasm, transanally removed, revealed the presence of a polypoid melanoma partially involving the resection margin. Nor metastases nor limph-node involvement were found at the total-body CT scan and at a CT-PET. C-KIT examinati…

PrognosiHemorrhoidsDiagnosis DifferentialTreatment RefusalAnus NeoplasmAntineoplastic Combined Chemotherapy ProtocolsHumansmucosal melanomaNeoplasm Invasivenessrectal bleedingMelanomaDigestive System Surgical ProceduresNeoplasm InvasiveneAntineoplastic Combined Chemotherapy Protocolano-rectal melanoma; mucosal melanoma; rectal bleedingRectal DiseaseDigestive System Surgical ProcedureMiddle AgedAnus NeoplasmsPrognosisRectal DiseasesChemotherapy Adjuvantano-rectal melanomaFemaleHemorrhoidGastrointestinal HemorrhageHuman
researchProduct